Development of tetracycline-serratiopeptidase-containing periodontal gel: Formulation and preliminary clinical study

AAPS PharmSciTech

Volumn 7, Issue 3, 2006, Pages

  Maheshwari, Manish ^a   Miglani, Gunjan ^b   Mali, Amita ^b   Paradkar, Anant ^a   Yamamura, Shigeo ^c   Kadam, Shivajirao ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b BHARATI VIDYAPEETH UNIVERSITY   (India)

^c TOHO UNIVERSITY   (Japan)

Author keywords

Aerosil; Clinical study; Periodontitis; Pluronic; Serratiopeptidase

Indexed keywords

AEROSIL; POLOXAMER; POLYMER; PROTEINASE; SERRATIOPEPTIDASE; TETRACYCLINE; PEPTIDE HYDROLASE; TETRACYCLINE DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ADHESION; ADULT; ARTICLE; BACILLUS LICHENIFORMIS; BACILLUS SUBTILIS; BACTERIAL COUNT; CLINICAL ARTICLE; COCCIDIA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; DRUG RESEARCH; ENZYME STABILITY; FEMALE; GEL; GELATION; HUMAN; IN VIVO STUDY; MALE; MELTING POINT; PERIODONTITIS; POLARIZATION MICROSCOPY; PREVENTIVE DENTISTRY; SPIROCHETE; SUSTAINED RELEASE FORMULATION; TREATMENT OUTCOME; VISCOSITY; CHEMISTRY; CLINICAL TRIAL; DRUG COMBINATION; PERIODONTAL DISEASE;

CHEMISTRY, PHARMACEUTICAL; DRUG COMBINATIONS; GELS; HUMANS; PEPTIDE HYDROLASES; PERIODONTAL DISEASES; TETRACYCLINES;

EID: 33749062417     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt070356     Document Type: Article

References (38)

1. Veyries ML, Couarraze G, Geiger S, et al. Controlled release of vancomycin from poloxamer 407 gels. Int J Pharm. 1999;192: 183-193.
2. Paavola A, Kilpelaine I, Yliruusi J, Rosenberg P. Controlled release injectable liposomal gel of ibuprofen for epidural. analgesia. Int J Pharm. 2000;199:85-93.
3. Kim SY, Ha JC, Lee M. Poly (ethylene oxide)-poly (propylene oxide)-poly (ethylene oxide)/ poly (caprolactone) amphiphilic block copolymer nanospheres, II: thermoresponsive behavior. J Control Release. 2000;65:345-358.
4. Ricci EJ, Lunardi L, Nanclares DMA, Marchetti JM. Sustained release of lidocaine from Poloxamer 407 gels. Int J Pharm. 2005; 288:235-244.
5. Pisal SS, Paradkar AR, Mahadik KR, Kadam SS. Pluronic gels for nasal delivery of Vitamin B12, Part I: preformulation study. Int J Pharm. 2004;270:37-45.
6. Pandit N, Trygstad T, Croy S, Bohorquez; M, Kock C. Effect of salt on micellization, clouding and solubilization behavior of pluronic F127 solutions. J Colloid Interface Sci. 2000;222:213-220.
7. El-Kamel AH. In vitro and in vivo evaluation of pluronic F127 based ocular delivery system for timolol maleate. Int J Pharm. 2002; 241:47-55.
8. Lin H, Sung KC. Carbopol/pluronic phase change solution for ophthalmic drug delivery. J Control Release. 2000;69:379-388.
9. Raghavan SR, Walls HJ, Khan SA. Rheology of silica dispersions in organic liquids: new evidence for solvation forces dictated by hydrogen bonding. Langmuir. 2000;16:7920-7930.
10. Shah MH, Paradkar A. Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme. Int J Pharm. 2005;294:161-171.
11. Adriaens PA, Edwards CA, De-Boever JA, Loesche WJ. Ultrastructural observation on bacterial invasion in cementum and radicular dentin of periodontally diseased human teeth. J Periodontol. 1988;59:493-503.
12. Noyan U, Yilmaz S, Kuru B, Kadir T, Acar O, Buget EA. Clinical and microbiological evaluation of systemic and local metronidazole delivery in adult periodontitis patients. J Clin Periodontol. 1997; 24:158-165.
13. Medlicott NJ, Rathbone MJ, Tucker IG, Hol-Borow DW. Delivery systems for the administration of drugs to the periodontal pocket. Adv Drug Deliv Rev. 1994;13:181-203.
14. Stoltze K, Stellfeld M. Systemic absorption of metronidazole after application of a metronidazole 25% dental gel. J Clin Periodontol. 1992;19:693-697.
15. Goodson JM, Holborow D, Dunn RL, Hogan P, Dunham S. Monolithic tetracycline-containing fibers for controlled delivery to periodontal pockets. J Periodontol. 1983;54:575-579.
16. Killoy WJ. The use of locally delivered chlorhexidine in the treatment of periodontitis: clinical results. J Clin Periodontol. 1998;25:953-958.
17. Norling T, Lading P, Engstrom S, Larsson K, Nissen SS. Formulation of a drug delivery system based on a mixture of monoglycerides and triglycerides for use in the treatment of periodontal disease. J Clin Periodontol. 1992; 19:687-692.
18. Mazzone A, Catalan M, Costanzo M, et al. Evaluation of serratiopeptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double blind, randomized trial versus placebo. J Int Med Res. 1990;18:379-388.
19. Malmsten M, Lindman B. Self-assembly in aqueous block copolymer solutions. Macromolecules. 1992;25:5440-5445.
20. Schmolka IR. Artificial skin, I: preparation and properties of pluronic F 127 gels for treatment of burns. J Biomed Mater Res. 1972;6:571-582.
21. Rosevear FB. The microscopy of the liquid crystalline neat and middle phases of soaps and synthetic detergents. J Am Oil Chem Soc. 1954;13:628-638.
22. Miller SC, Donovan MD. Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits. Int J Pharm. 1982; 12:147-152.
23. Nielsen LS, Schubert L, Hansen J. Bioadhesive drug delivery system, I: characterization of mucoadhesive properties of systems based on glyceryl monooleate and glyceryl. monolinoleate. Eur J Pharm Sci. 1998;6:231-239.
24. Korsmeyer RW, Gurny R, Doelker EM, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25-35.
25. Institute of Medicine. Food Chemical codex. 5th ed. Washington, DC: National Academies Press; 2003:495-496.
26. Turesky S, Gilmore ND, Glickman I. Reduced plaque formation by the chloromethyl analogue of vitamin C. J Periodontol. 1970;41:41-43.
27. Loee H, Silness J. Periodontal disease in pregnancy. Acta Odontol Scand. 1963;21:533-542.
28. Muhlemann-HR, Son S. Gingival sulcus bleeding - a leading symptom in initial gingivitis. Helv Odontol Acta. 1971;15:107-113.
29. Clark DC, Quee TC, Bergeron MJ. Reliability of attachment level measurements using the cementoenamel junction and plastic stent. J Periodontol. 1987;58:115-118.
30. Ivanova R, Lindman B, Alexandris P. Effect of pharmaceutically acceptable glycols on the stability of the liquid crystalline gels formed by poloxamer 407 in water. J Colloid Interface Sci. 2002;2-52: 226-235.
31. Wanka G, Hoffmann H, Ulbricht V. Phase diagrams and aggregation behavior of poly (oxyethylene) - poly (oxypropylene)-poly (oxyethylene) triblock copolymers in aqueous solutions. Macromolecules. 1994; 27:4145-4159.
32. Cabana A, Ait-kadi A, Juhasz J. Study of the gelation process of polyethylene oxide-polypropylene oxide-polyethylene oxide copolymer (poloxamer 407) aqueous solution. J Colloid Interface Sci. 1997; 190:307-312.
33. Song MJ, Lee DS, Ahn JH, Kim DJ, Kim SC. Dielectric behavior during sol-gel transition of PEO-PPO-PEO triblock copolymer aqueous solution. Polymer Bulletin. 2000;43:497-504.
34. Bohorquez M, Kock C, Tryastad T, Pandit N. A study of the temperature-dependent micellization of pluronic F127. J Colloid Interface Sci. 1999;216:34-40.
35. Esposito E, Carotta V, Scabbia A, et al. Comparative analysis of tetracycline-containing dental gels: poloxamer- and monoglyceride-based formulations. Int J Pharm. 1996; 142:9-23.
36. Shah JC, Sadhale Y, Chilukuri DM. Cubic phase gels as drug delivery systems. Adv Drug Deliv Rev. 2001;47:229-250.
37. Stratton LP, Dong A, Manning MC, Carpenter F. Drug delivery matrix containing native protein precipitate suspended in poloxamer gel. J Pharm Sci. 1997;86:1006-1010.
38. Heijl L, Dahlen V, Sundin Y. A 4-quadrant comparative study of periodontal treatment using tetracycline-containing drug delivery fibers and scaling. J Clin Periodontol. 1991; 18:111-116.